Funding for this research was provided by:
Wellcome (98,461/Z/12/Z, 102,616/Z)
Received: 11 June 2020
Accepted: 21 October 2020
First Online: 1 February 2021
Ethics approval and consent to participate
: The AMoSS study procedures were reviewed by and received ethical approval from the NRES Research Ethics Committee East of England—Norfolk (13/EE/0288). Informed written consent was obtained from all participants involved.
: Not applicable.
: GMG is a NIHR Emeritus Senior Investigator, holds shares in P1vital Ltd and P1vital Products Ltd and has served as consultant, advisor or CME speaker in the last 3 years for Compass pathways, Evapharm, Janssen, Lundbeck, Medscape, P1Vital, Sage, Servier. ACB receives salaries from P1vital Ltd. NMMcG, MN, and KEAS declare no competing interests. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.